Skip to main content

Horizon Therapeutics plc to Participate in Upcoming Investor Conferences

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following upcoming conferences:

Jefferies Virtual Health Care Conference

  • Date: Thursday, June 3, 2021
  • Presentation Time: 1 p.m. ET

BMO Biopharma Day: Spotlight on Rare Disease and Ophthalmology

  • Date: Tuesday, June 22, 2021
  • Presentation Time: 10 a.m. ET

The conference presentations will be webcast live and may be accessed by visiting Horizon's website at A replay of the webcasts will be available following the events.

About Horizon

Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit and follow us on Twitter, LinkedIn, Instagram and Facebook.


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.